Latest Glioma Stories
Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma.
In this phase two study, 50 percent of glioblastoma patients lived for two years, an encouraging result for one of the most deadly cancers that often kills patients within one year of diagnosis
Astrocytomas and oligodendrogliomas are subtypes of a brain cancer called 'glioma'.
HOUSTON, June 27, 2014 /PRNewswire/ -- The Burzynski Research Institute, Inc.
Giving low doses of a particular targeted agent with a cancer-killing virus might improve the effectiveness of the virus as a treatment for cancer.
SAN DIEGO, June 17, 2014 /PRNewswire/ -- DNAtrix, Inc., experts in oncolytic virus development, today announced that the U.S.
Analysis of PRiDe, a U.S.
LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
New genomic research led by UC San Francisco (UCSF) scientists reveals that two common gene variants that lead to longer telomeres, the caps on chromosome ends thought by many scientists to confer health by protecting cells from aging, also significantly increase the risk of developing the deadly brain cancers known as gliomas.
- totally perplexed and mixed up.